Shares of Relay Therapeutics, Inc. (RLAY) have gained 37.4% over the past four weeks to close the last trading session at $7.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$13.6 indicates a potential upside of 86.1%.The average comprises 10 short-term price targets ranging from a low of $4.00 to a high of$19.00, with a standard deviation of $4.22. While the lowest estimate ...